159 related articles for article (PubMed ID: 24661883)
1. Discovery of Apo-A1 as a potential bladder cancer biomarker by urine proteomics and analysis.
Li C; Li H; Zhang T; Li J; Liu L; Chang J
Biochem Biophys Res Commun; 2014 Apr; 446(4):1047-52. PubMed ID: 24661883
[TBL] [Abstract][Full Text] [Related]
2. [Significance of apolipoprotein A1 as biomarker for early diagnosis and classification of bladder urothelial carcinoma].
Li CY; Li HJ; Zhang T; Gao HS; Chang JW; Men XL; Wu J; Li JM
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2013 Apr; 31(4):266-70. PubMed ID: 23595303
[TBL] [Abstract][Full Text] [Related]
3. Discovery of potential bladder cancer biomarkers by comparative urine proteomics and analysis.
Lei T; Zhao X; Jin S; Meng Q; Zhou H; Zhang M
Clin Genitourin Cancer; 2013 Mar; 11(1):56-62. PubMed ID: 22982111
[TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
[TBL] [Abstract][Full Text] [Related]
5. Discovery of novel bladder cancer biomarkers by comparative urine proteomics using iTRAQ technology.
Chen YT; Chen CL; Chen HW; Chung T; Wu CC; Chen CD; Hsu CW; Chen MC; Tsui KH; Chang PL; Chang YS; Yu JS
J Proteome Res; 2010 Nov; 9(11):5803-15. PubMed ID: 20806971
[TBL] [Abstract][Full Text] [Related]
6. Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients.
Chen CL; Lai YF; Tang P; Chien KY; Yu JS; Tsai CH; Chen HW; Wu CC; Chung T; Hsu CW; Chen CD; Chang YS; Chang PL; Chen YT
J Proteome Res; 2012 Dec; 11(12):5611-29. PubMed ID: 23082778
[TBL] [Abstract][Full Text] [Related]
7. UPK3A: a promising novel urinary marker for the detection of bladder cancer.
Lai Y; Ye J; Chen J; Zhang L; Wasi L; He Z; Zhou L; Li H; Yan Q; Gui Y; Cai Z; Wang X; Guan Z
Urology; 2010 Aug; 76(2):514.e6-11. PubMed ID: 20346489
[TBL] [Abstract][Full Text] [Related]
8. [Application of urinary proteomics in early diagnosis of bladder urothelial carcinoma].
Li HJ; Li CY; Zhang T; Chen JJ; Wang SX; Chang JW; Jiang SF; Zhang GL; Li JM
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2013 Apr; 31(4):262-5. PubMed ID: 23595302
[TBL] [Abstract][Full Text] [Related]
9. The simultaneous use of telomerase, cytokeratin 20 and CD4 for bladder cancer detection in urine.
Siracusano S; Niccolini B; Knez R; Tiberio A; Benedetti E; Bonin S; Ciciliato S; Pappagallo GL; Belgrano E; Stanta G
Eur Urol; 2005 Mar; 47(3):327-33. PubMed ID: 15716196
[TBL] [Abstract][Full Text] [Related]
10. Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection.
Urakami S; Shiina H; Enokida H; Kawakami T; Kawamoto K; Hirata H; Tanaka Y; Kikuno N; Nakagawa M; Igawa M; Dahiya R
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2109-16. PubMed ID: 16609023
[TBL] [Abstract][Full Text] [Related]
11. Identification of Apo-A1 as a biomarker for early diagnosis of bladder transitional cell carcinoma.
Li H; Li C; Wu H; Zhang T; Wang J; Wang S; Chang J
Proteome Sci; 2011 Apr; 9(1):21. PubMed ID: 21496341
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of urine CYFRA 21-1 for the detection of primary and recurrent bladder carcinoma.
Nisman B; Barak V; Shapiro A; Golijanin D; Peretz T; Pode D
Cancer; 2002 Jun; 94(11):2914-22. PubMed ID: 12115379
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of two new urinary tumor markers: bladder tumor fibronectin and cytokeratin 18 for the diagnosis of bladder cancer.
Sánchez-Carbayo M; Urrutia M; González de Buitrago JM; Navajo JA
Clin Cancer Res; 2000 Sep; 6(9):3585-94. PubMed ID: 10999749
[TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis of urinary biomarker candidates for nonmuscle invasive bladder cancer.
Lindén M; Lind SB; Mayrhofer C; Segersten U; Wester K; Lyutvinskiy Y; Zubarev R; Malmström PU; Pettersson U
Proteomics; 2012 Jan; 12(1):135-44. PubMed ID: 22065568
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of cytology, nuclear matrix protein 22 (NMP22) test, and urinary bladder cancer II (UBC II) test in early recurrent transitional cell carcinoma of the bladder.
Kibar Y; Goktas S; Kilic S; Yaman H; Onguru O; Peker AF
Ann Clin Lab Sci; 2006; 36(1):31-8. PubMed ID: 16501234
[TBL] [Abstract][Full Text] [Related]
16. Development and Validation of Urine-based Peptide Biomarker Panels for Detecting Bladder Cancer in a Multi-center Study.
Frantzi M; van Kessel KE; Zwarthoff EC; Marquez M; Rava M; Malats N; Merseburger AS; Katafigiotis I; Stravodimos K; Mullen W; Zoidakis J; Makridakis M; Pejchinovski M; Critselis E; Lichtinghagen R; Brand K; Dakna M; Roubelakis MG; Theodorescu D; Vlahou A; Mischak H; Anagnou NP
Clin Cancer Res; 2016 Aug; 22(16):4077-86. PubMed ID: 27026199
[TBL] [Abstract][Full Text] [Related]
17. Urinary CYFRA 21.1 is not a useful marker for the detection of recurrences in the follow-up of superficial bladder cancer.
Fernandez-Gomez J; Rodríguez-Martínez JJ; Barmadah SE; García Rodríguez J; Allende DM; Jalon A; Gonzalez R; Alvarez-Múgica M
Eur Urol; 2007 May; 51(5):1267-74. PubMed ID: 17207912
[TBL] [Abstract][Full Text] [Related]
18. Expression of CD147, BIGH3 and Stathmin and their potential role as diagnostic marker in patients with urothelial carcinoma of the bladder.
Bhagirath D; Abrol N; Khan R; Sharma M; Seth A; Sharma A
Clin Chim Acta; 2012 Oct; 413(19-20):1641-6. PubMed ID: 22626996
[TBL] [Abstract][Full Text] [Related]
19. Urinary bladder tumor markers.
Lokeshwar VB; Selzer MG
Urol Oncol; 2006; 24(6):528-37. PubMed ID: 17138134
[TBL] [Abstract][Full Text] [Related]
20. Neural network using combined urine nuclear matrix protein-22, monocyte chemoattractant protein-1 and urinary intercellular adhesion molecule-1 to detect bladder cancer.
Parekattil SJ; Fisher HA; Kogan BA
J Urol; 2003 Mar; 169(3):917-20. PubMed ID: 12576812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
